Search Results

There are 10213 results for: content related to: The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma

  1. You have free access to this content
    Poster Session 1: Cellular Immunobiology, Preservation, and Cell Transplantation in Transplant; Clinical: Hepatocellular Carcinoma and Cholangiocarcinoma

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 380A–456A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28212

  2. You have free access to this content
    Interim analysis of START: Study in asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial

    International Journal of Cancer

    Volume 132, Issue 10, 15 May 2013, Pages: 2448–2458, Young-Hwa Chung, Guohong Han, Jung-Hwan Yoon, Jijin Yang, Jianhua Wang, Guo-Liang Shao, Byung Ik Kim, Teng-Yu Lee and Yee Chao

    Version of Record online : 28 NOV 2012, DOI: 10.1002/ijc.27925

  3. You have free access to this content
    The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: Final results of the START trial

    International Journal of Cancer

    Volume 136, Issue 6, 15 March 2015, Pages: 1458–1467, Yee Chao, Young-Hwa Chung, Guohong Han, Jung-Hwan Yoon, Jijin Yang, Jianhua Wang, Guo-Liang Shao, Byung Ik Kim and Teng-Yu Lee

    Version of Record online : 16 SEP 2014, DOI: 10.1002/ijc.29126

  4. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  5. Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 1036–1047, Annagiulia Gramenzi, Rita Golfieri, Cristina Mosconi, Alberta Cappelli, Alessandro Granito, Alessandro Cucchetti, Sara Marinelli, Cinzia Pettinato, Virginia Erroi, Silvia Fiumana, Luigi Bolondi, Mauro Bernardi, Franco Trevisani and on behalf ofBLOG (Bologna Liver Oncology Group)

    Version of Record online : 20 MAY 2014, DOI: 10.1111/liv.12574

  6. Sorafenib in combination with transarterial chemoembolization and bronchial arterial chemoinfusion in the treatment of hepatocellular carcinoma with pulmonary metastasis

    Asia-Pacific Journal of Clinical Oncology

    Volume 8, Issue 2, June 2012, Pages: 156–163, Feng DUAN, Mao Qiang WANG, Feng Yong LIU, Zhi Jun WANG, Peng SONG and Yan WANG

    Version of Record online : 24 APR 2012, DOI: 10.1111/j.1743-7563.2012.01542.x

  7. Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: A propensity score-based weighting

    Journal of Digestive Diseases

    Volume 16, Issue 3, March 2015, Pages: 143–151, Masaaki Kondo, Manabu Morimoto, Tomohiro Ishii, Akito Nozaki, Hiroyuki Fukuda, Kazushi Numata, Satoshi Kobayashi, Shinichi Ohkawa, Hisashi Hidaka, Takahide Nakazawa, Akitaka Shibuya, Chiaki Okuse, Michihiro Suzuki, Kentaro Sakamaki, Satoshi Morita, Shin Maeda and Katsuaki Tanaka

    Version of Record online : 27 MAR 2015, DOI: 10.1111/1751-2980.12221

  8. Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: A propensity score matching study

    Journal of Digestive Diseases

    Volume 14, Issue 4, April 2013, Pages: 181–190, Wei Bai, Yong Ji Wang, Yan Zhao, Xing Shun Qi, Zhan Xin Yin, Chuang Ye He, Rui Jun Li, Kai Chun Wu, Jie Lai Xia, Dai Ming Fan and Guo Hong Han

    Version of Record online : 21 MAR 2013, DOI: 10.1111/1751-2980.12038

  9. You have free access to this content
    Transarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendations

    HPB

    Volume 17, Issue 1, January 2015, Pages: 52–65, Gino Boily, Jean-Pierre Villeneuve, Luc Lacoursière, Prosanto Chaudhury, Félix Couture, Jean-François Ouellet, Réal Lapointe, Stéphanie Goulet, Normand Gervais and the Comité de l'évolution des pratiques en oncologie

    Version of Record online : 24 JUN 2014, DOI: 10.1111/hpb.12273

  10. Sorafenib in a hepatocellular carcinoma patient with end-stage renal failure: A pharmacokinetic study

    Hepatology Research

    Volume 44, Issue 6, June 2014, Pages: 685–688, Takamichi Ishii, Etsuro Hatano, Kojiro Taura, Tomoyuki Mizuno, Tomoki Kawai, Masahide Fukudo, Toshiya Katsura and Shinji Uemoto

    Version of Record online : 30 MAY 2013, DOI: 10.1111/hepr.12156

  11. You have free access to this content
    Poster Session 3: Cellular Immunobiology and Clinical Hepatobiliary Neoplasia

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 828A–889A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27524

  12. Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC

    Liver International

    Volume 35, Issue 2, February 2015, Pages: 620–626, Jens Ricke, Karsten Bulla, Frank Kolligs, Markus Peck-Radosavljevic, Peter Reimer, Bruno Sangro, Eckart Schott, Kerstin Schütte, Chris Verslype, Jerzy Walecki, Peter Malfertheiner and for the SORAMIC study group

    Version of Record online : 8 JUL 2014, DOI: 10.1111/liv.12622

  13. You have free access to this content
    Liver Cancer

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1213A–1276A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26883

  14. Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 12, December 2013, Pages: 1834–1841, Daisuke Miyaki, Hiroshi Aikata, Hiromi Kan, Hatsue Fujino, Ayako Urabe, Keiichi Masaki, Takayuki Fukuhara, Tomoki Kobayashi, Noriaki Naeshiro, Takashi Nakahara, Tomokazu Kawaoka, Akira Hiramatsu, Shoichi Takahashi, Masaki Ishikawa, Hideaki Kakizawa, Kazuo Awai and Kazuaki Chayama

    Version of Record online : 22 NOV 2013, DOI: 10.1111/jgh.12311

  15. A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib

    Liver International

    Volume 35, Issue 9, September 2015, Pages: 2147–2154, Yu Yang, Feng Wen, Jianliang Li, Pengfei Zhang, Wenhui Yan, Ping Hao, Feng Xia, Feng Bi and Qiu Li

    Version of Record online : 7 MAR 2015, DOI: 10.1111/liv.12805

  16. You have free access to this content
    Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma

    Cancer

    Volume 118, Issue 1, 1 January 2012, Pages: 147–156, Julien Edeline, Eveline Boucher, Yan Rolland, Elodie Vauléon, Marc Pracht, Christophe Perrin, Catherine Le Roux and Jean-Luc Raoul

    Version of Record online : 28 JUN 2011, DOI: 10.1002/cncr.26255

  17. You have full text access to this OnlineOpen article
    Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation

    International Journal of Cancer

    Volume 136, Issue 6, 15 March 2015, Pages: 1434–1444, Floris H. Groenendijk, Wouter W. Mellema, Eline van der Burg, Eva Schut, Michael Hauptmann, Hugo M. Horlings, Stefan M. Willems, Michel M. van den Heuvel, Jos Jonkers, Egbert F. Smit and René Bernards

    Version of Record online : 8 AUG 2014, DOI: 10.1002/ijc.29113

  18. You have full text access to this OnlineOpen article
    FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib-mediated cytotoxicity

    Pharmacology Research & Perspectives

    Volume 3, Issue 5, October 2015, Dilruba Ahmed, Petra J. de Verdier, Charlotta Ryk, Oscar Lunqe, Per Stål and Jenny Flygare

    Version of Record online : 19 AUG 2015, DOI: 10.1002/prp2.171

  19. You have free access to this content
    Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres

    International Journal of Clinical Practice

    Volume 71, Issue 11, November 2017, Eric A. Wang, Jeff P. Stein, Ross J. Bellavia and Scott R. Broadwell

    Version of Record online : 30 JUL 2017, DOI: 10.1111/ijcp.12972

  20. You have free access to this content
    Incidence and Risk of Sorafenib-Induced Hypertension: A Systematic Review and Meta-Analysis

    The Journal of Clinical Hypertension

    Volume 16, Issue 3, March 2014, Pages: 177–185, Yan Li, Shun Li, Yaofeng Zhu, Xinyue Liang, Hui Meng, Jun Chen, Dongqing Zhang, Hu Guo and Benkang Shi

    Version of Record online : 12 MAR 2014, DOI: 10.1111/jch.12273